Cargando…
Combinational antitumor strategies of exosomes as drug carriers: Mini review
Cancer therapies have made tremendous progress in the last decade, but monotherapy still has apparent limitations and lacks therapeutic efficacy. Thus, the simultaneous administration of multiple drugs has been widely explored and has shown better outcomes. Exosomes, deriving from almost all living...
Autores principales: | Xiao, Guixiu, Xu, Zihan, Luo, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897293/ https://www.ncbi.nlm.nih.gov/pubmed/36744207 http://dx.doi.org/10.3389/fphar.2022.1107329 |
Ejemplares similares
-
Exosomes: potential diagnostic markers and drug carriers for adenomyosis
por: Cheng, Wen-Xiu, et al.
Publicado: (2023) -
Exosomes as Drug Carriers in Anti-Cancer Therapy
por: Chen, Lan, et al.
Publicado: (2022) -
Zeolites as Carriers of Antitumor Ribonuclease Binase
por: Khojaewa, Vera, et al.
Publicado: (2019) -
Exosomes As Potential Biomarkers and Targeted Therapy in Colorectal Cancer: A Mini-Review
por: Hon, Kha Wai, et al.
Publicado: (2017) -
Mini Review: Current Trends and Understanding of Exosome Therapeutic Potential in Corneal Diseases
por: Tiwari, Anil, et al.
Publicado: (2021)